HIV, HBV, and HCV are known as the most common blood-borne viral infections worldwide. Individuals referring to drop-in centers (DICs) are considered as high-risk people exposed to infection with theses blood-borne viruses. The purpose of this study was to investigate the prevalence of HIV, HBV, and HCV infections among women referred to DICs in the western province of Lorestan, Iran. During the present cross-sectional study, after obtaining informed consent and a questionnaire, two blood samples were collected from 118 women referred to Lorestan DICs to be evaluated for HIV, HBV, and HCV infections. Accordingly, the samples were first screened by using the most common serological methods, and then by Real Time-PCR to detect viral genomes. The results were analyzed using Chi-square statistical test and binary logistic regressions. Out of the studied 118 blood samples, 8 (6.8%), 4 (3.4%), and 10 (8.5%) subjects tested positive for HIV, HBV, and HCV infection, respectively. Furthermore, our study showed that 5 (4.2%) subjects were positive for HCV/HIV coinfection, and 3 (2.5%) cases for HBV/HCV coinfection. Moreover, our data revealed that incarceration and STDs were the most important risk factors for HIV (OR=15.27 (95% CI; 3.74 - 62.89); P value=0.01) and HBV (OR=16 (95% CI; 1.57 - 42.34); P value=0.018) infections, respectively. Our results suggest that women referring to DICs are at risk of infection with blood-borne viruses such as HIV, HBV, and HCV, due to risky behaviors. Thus, precise diagnostic testing and implementation of preventive methods against blood and sexually transmitted infections are urgent in these high-risk groups. |
- Semá Baltazar C, Kellogg TA, Boothe M, Loarec A, de Abreu E, Condula M, et al. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique. Int. J. Drug Policy. 2021;90:103095.
- Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):1-187.
- Keramat F, Eini P, Majzoobi MM. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran. IRCMJ. 2011;13(1):42-6.
- Carobene M, Bolcic F, Farías MS, Quarleri J, Avila MM. HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina. J. Med. Virol. 2014;86(1):64-70.
- Shahesmaeili A, Mirzazadeh A, McFarland W, Sharifi H, Haghdoost AA, Soori H. Syringe Sharing in Drug Injecting Dyads: A Cross-Classified Multilevel Analysis of Social Networks. AIDS and Behav. 2018;22(1):10-8.
- Jary A, Dienta S, Leducq V, Le Hingrat Q, Cisse M, Diarra AB, et al. Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali. BMC Infect. Dis. 2019;19(1):1064.
- Melku M, Ambachew S, Enawgaw B, Abebe M, Abebe Z, Deressa T, et al. Sero-epidemiology and associated factors of HIV, HBV, HCV and syphilis among blood donors in Ethiopia: a systematic review and meta-analysis. BMC Infect. Dis. 2021;21(1):778.
- Rashti R, Alavian SM, Moradi Y, Sharafi H, Mohamadi Bolbanabad A, Roshani D, et al. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis. Arch. Virol. 2020;165(9):1947-58.
- Al-Mughales JA. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia. J. Med. Virol. 2016;88(9):1545-51.
- Puglia M, Stasi C, Da Frè M, Voller F. Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany. Braz J Infect Dis. 2016;20(4):330-4.
- Akbarzadeh V, Mumtaz GR, Awad SF, Weiss HA, Abu-Raddad LJ. HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis. BMC public health. 2016;16(1):1216.
- Scheibe A, Young K, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, et al. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). BMC Infect. Dis. 2020;20(1):655.
- Mahmoudvand S, Shokri S, Azaran A, Seyedian SS, Makvandi M, Mirzaei H, et al. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study. Ther Apher Dial. 2021;25(2):218-24.
- Moayedi-Nia S, Bayat Jozani Z, Esmaeeli Djavid G, Entekhabi F, Bayanolhagh S, Saatian M, et al. HIV, HCV, HBV, HSV, and syphilis prevalence among female sex workers in Tehran, Iran, by using respondent-driven sampling. AIDS care. 2016;28(4):487-90.
- Shahri SMH, Ansari-Moghadam F, Moghadam AAJHS. A Survey on HIV, HCV, and HBV and Related Factors Among the Homeless Population, Southeast of Iran. Health Scope. 2021;10(1).
- Foroughi M, Moayedi-Nia S, Shoghli A, Bayanolhagh S, Sedaghat A, Mohajeri M, et al. Prevalence of HIV, HBV and HCV among street and labour children in Tehran, Iran. Sex. Transm. Infect. 2017;93(6):421-3.
- Doosti-Irani A, Mokhaeri H, Chegini Sharafi A, Aghasadeghi MR, Hajimiragha M, Saki M, et al. Prevalence of HIV, HBV, and HCV and Related Risk Factors amongst Male Homeless People in Lorestan Province, the West of Iran: J Res Health Sci. 2017;17(1):373.
- Zhou YH, Yao ZH, Liu FL, Li H, Jiang L, Zhu JW, et al. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China. PloS one. 2012;7(8):e42937.
- Bagheri Amiri F, Mostafavi E, Mirzazadeh A. HIV, HBV and HCV Coinfection Prevalence in Iran--A Systematic Review and Meta-Analysis. PloS one. 2016;11(3):e0151946.
- Zhou YH, Liu FL, Yao ZH, Duo L, Li H, Sun Y, et al. Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PloS one. 2011;6(1):e16349.
|